Gene · 3660
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Harnessing Normal and Engineered Mesenchymal Stem Cells Derived Exosomes for Cancer Therapy: Opportunity and Challenges. | Int J Mol Sci | 2022 | 36430452 | PubTator, text mining | PubMed |
| Recruiting Immunity for the Fight against Colorectal Cancer: Current Status and Challenges. | Int J Mol Sci | 2022 | 36430176 | PubTator, text mining | PubMed |
| The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation. | Front Oncol | 2022 | 36419887 | PubTator, text mining | PubMed |
| The analysis of the pyroptosis-related genes and hub gene TP63 ceRNA axis in osteosarcoma. | Front Immunol | 2022 | 36389801 | PubTator, text mining | PubMed |
| Identification of a novel sepsis prognosis model and analysis of possible drug application prospects: Based on scRNA-seq and RNA-seq data. | Front Immunol | 2022 | 36389695 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis reveals novel key biomarkers in diabetic nephropathy. | SAGE Open Med | 2022 | 36385790 | PubTator, text mining | PubMed |
| Retraction statement: MicroRNA-520c enhances cell proliferation, migration, and invasion by suppressing IRF2 in gastric cancer. | FEBS Open Bio | 2022 | 36377846 | PubTator, text mining | PubMed |
| Long Non-Coding RNA CASC2 Functions as A Tumor Suppressor in Colorectal Cancer via Modulating The miR-18a-5p/BTG3 Pathway. | Cell J | 2022 | 36377216 | PubTator, text mining | PubMed |
| Induction of pyroptotic cell death as a potential tool for cancer treatment. | J Inflamm (Lond) | 2022 | 36376979 | PubTator, text mining | PubMed |
| The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity. | Immunity | 2022 | 36370712 | PubTator, text mining | PubMed |
| Identification of the hub susceptibility genes and related common transcription factors in the skeletal muscle of Type 2 Diabetes Mellitus. | BMC Endocr Disord | 2022 | 36368953 | PubTator, text mining | PubMed |
| Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36358885 | PubTator, text mining | PubMed |
| Positive selection-driven fixation of a hominin-specific amino acid mutation related to dephosphorylation in IRF9. | BMC Ecol Evol | 2022 | 36357830 | PubTator, text mining | PubMed |
| Mining the transcriptome of target tissues of autoimmune and degenerative pancreatic β-cell and brain diseases to discover therapies. | iScience | 2022 | 36345338 | PubTator, text mining | PubMed |
| A CD8+ T cell-associated immune gene panel for prediction of the prognosis and immunotherapeutic effect of melanoma. | Front Immunol | 2022 | 36341357 | PubTator, text mining | PubMed |
| Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers. | Front Bioeng Biotechnol | 2022 | 36338118 | PubTator, text mining | PubMed |
| Screening of potential biomarkers in peripheral blood of patients with depression based on weighted gene co-expression network analysis and machine learning algorithms. | Front Psychiatry | 2022 | 36325528 | PubTator, text mining | PubMed |
| FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. | Nat Commun | 2022 | 36323682 | PubTator, text mining | PubMed |
| Pyroptosis is a drug target for prevention of adverse cardiac remodeling: The crosstalk between pyroptosis, apoptosis, and autophagy. | J Biomed Res | 2022 | 36320147 | PubTator, text mining | PubMed |
| IRF2 Cooperates with Phosphoprotein of Spring Viremia of Carp Virus to Suppress Antiviral Response in Zebrafish. | J Virol | 2022 | 36314827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3660/papers?page=20